We innovate through integration, grow through exploration, and continuously strive for excellence.
Activating endogenous anti-tumor immunity to break the barriers of cancer treatment and bring hope to patients.
MAaGI brings together multidisciplinary expertise in tumor ablation, immunotherapy, biothermal physics, and medical imaging, with over 20 years of dedication to thermophysical immunotherapy for cancer.
Our multimodal platform has received high recognition from leading clinical experts, as well as Chinese national Innovative Medical Device designation and support from a key project of the Ministry of Science and Technology. We remain committed to exploration and interdisciplinary collaboration, ushering in a new era of minimally invasive cancer therapy.
Multimodal Tumor Thermophysical Immunotherapy
SCI Academic Papers & Patents
Clinical Partners Among the Top 100 Hospitals
Awarded one of the first batch projects of the "Research and Development of Digital Diagnostic Equipment" key initiative under the National Key R&D Program.
Latest research on multimodal tumor therapy published in Science.
Expert consensus on “multimodal therapy technology” was released.
The first product ” Multimodal Tumor Thermal Therapy System” entered the special approval procedure for innovative medical devices.
Multicenter clinical trial of the Multimodal Tumor Thermal Therapy System completed.
Breakthrough product “Multimodal Tumor Thermal Therapy System” approved for Chinese market launch.
National Key R&D Program of China — "Diagnostic Equipment and Biomedical Materials" key project awarded.
The system approved for pulmonary indications.
Awarded one of the first batch projects of the "Research and Development of Digital Diagnostic Equipment" key initiative under the National Key R&D Program.
Latest research on multimodal tumor therapy published in Science.
Expert consensus on “multimodal therapy technology” was released.
The first product ” Multimodal Tumor Thermal Therapy System” entered the special approval procedure for innovative medical devices.
Multicenter clinical trial of the Multimodal Tumor Thermal Therapy System completed.
Breakthrough product “Multimodal Tumor Thermal Therapy System” approved for Chinese market launch.
National Key R&D Program of China — "Diagnostic Equipment and Biomedical Materials" key project awarded.
The system approved for pulmonary indications.
5th Floor, Building 63, No. 421 Hongcao Road, Xuhui District, 200233, Shanghai, China
Tel：4008820922
office@magic-med.cn
